Vira Shield 6+Somnus

This page contains information on Vira Shield 6+Somnus for veterinary use.
The information provided typically includes the following:

Vira Shield 6+Somnus Indications
Warnings and cautions for Vira Shield 6+Somnus
Direction and dosage information for Vira Shield 6+Somnus

Vira Shield 6+Somnus

This treatment applies to the following species:

Company: Elanco (Farm Animal)

Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine

Killed Virus

Haemophilus Somnus Bacterin

For Use In Animals Only

Vira Shield 6+Somnus Indications

This product has been shown to be effective for the vaccination of healthy cattle, 3 months of age or older against disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD Type 1 and BVD Type 2), parainfluenza Type 3 (PI₃), and bovine respiratory syncytial (BRSV) viruses and Haemophilus somnus. The duration of immunity against BVD Type 2 is at least 11 months. The duration of immunity for the remaining antigens has not been established. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

Produced from non-cytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates. This product is safe for use in pregnant cows and heifers.

ADJUVANT: Xtend™ SP.

Directions For Use

Shake well before using. Administer 5 mL intramuscularly in the neck. Revaccinate in 4 to 5 weeks. Vaccinate dairy cows at dry-off. Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. The presence of maternal antibody is known to interfere with the development of active immunity in calves and additional boosters will be required in most young animals. For advice on revaccination frequency, in general or in the face of maternal antibody, consult a veterinarian.

Precautions

Store out of direct sunlight at 2° to 8°C (35° to 46°F). DO NOT FREEZE. Use entire contents when first opened. Do not mix with other products, except as specified on the label. In case of human exposure, contact a physician. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.

VLN/PCN 196/44C5.20

Elanco US Inc., Fort Dodge, IA 50501 USA; 1-800-428-4441

Vira Shield, Xtend, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

10 Doses	50 mL	YL102585A
50 Doses	250 mL	YL102585B

CPN: 1114089.5

ELANCO US, INC.
Distributed by ELANCO US, INC.
2500 INNOVATION WAY, GREENFIELD, IN, 46140

Customer Service:		317-276-1262
Technical Service:		800-428-4441
Website:		www.elanco.us
Email:		elanco@elanco.com

THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.